Results 11 to 20 of about 29,949 (204)
Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports [PDF]
Lichen planus (LP) is an uncommon mucocutaneous inflammatory condition, that is immunologically mediated, typically pruritic and often recurs. The currently advocated therapies are either not highly effective or associated with severe side effects ...
Rahul P. Patel +6 more
doaj +4 more sources
Utilizing enoxaparin in the management of STEMI
Andrea Rubboli1, Alessandro Capecchi2, Giuseppe Di Pasquale11Division of Cardiology, Maggiore Hospital, Bologna, Italy; 2Division of Cardiology, General Hospital, Bentivoglio, ItalyAbstract: The use of enoxaparin in conjunction with thrombolysis in ST ...
Andrea Rubboli +2 more
doaj +1 more source
Linda Tahaineh,1 Sahar M Edaily,1 Shadi F Gharaibeh2 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jerash University,
Tahaineh L, Edaily SM, Gharaibeh SF
doaj +1 more source
Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients
Low-molecular-weight heparins are a class of drugs derived from the enzymatic depolymerization of unfractionated heparin that includes enoxaparin. Several studies have been performed on enoxaparin in recent years, in particular for the prevention and ...
Egidio Imbalzano +8 more
doaj +2 more sources
Inflammatory bowel diseases, such as ulcerative colitis, cause significant morbidity and decreased quality of life. The currently available treatments are not effective in all patients, can be expensive and have potential to cause severe side effects ...
Qi Ying Lean +7 more
doaj +2 more sources
An In Vitro Study Simulating Prophylactic Anticoagulation in Haemophilia A and B [PDF]
ABSTRACT Introduction Patients with haemophilia A (HA) and haemophilia B (HB) are at increased bleeding risk. A recent guidance document suggests considering pharmacological thromboprophylaxis on a case‐by‐case basis in these patients undergoing surgery at high‐risk of venous thromboembolism.
Riva N +8 more
europepmc +2 more sources
Equivalence between branded enoxaparin and biosimilar enoxaparin.
Equivalence between branded enoxaparin and biosimilar enoxaparin.
Chadli Dziri (14048856) +7 more
core +1 more source
Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).
Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856) +7 more
core +1 more source
Ixodes ricinus‐Contact Phase Inhibitor Promotes Functional Recovery and Attenuates Neutrophil Associated Neuroinflammation After Experimental Intracerebral Hemorrhage [PDF]
Ixodes ricinus‐Contact Phase Inhibitor (Ir‐CPI), a selective FXIa/XIIa inhibitor with reported thromboinflammatory modulatory properties, improves recovery after intracerebral hemorrhage (ICH) without increasing bleeding. By targeting thromboinflammation, Ir‐CPI limits neutrophil infiltration and NET formation, reducing secondary neuronal injury. These
Demoulin S +5 more
europepmc +2 more sources
Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin
Abstract Introduction: Earlier this year, heparin was found to be contaminated with a non-heparin sulfated polymer identified as oversulfated chondroitin sulfate (OSCS). The presence of this contaminant was associated with severe adverse reactions such as hypotension and anaphylaxis, leading to death in some patients.
Jacqueline Kuziej +6 more
openaire +1 more source

